YSYanyan Song

Yanyan Song

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yanyan Song has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Jieting Tang

    Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Diseases, National Health Commission (NHC) Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University

    2 shared publications
  • Minyan Ye

    Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital

    2 shared publications
  • Sha Huang

    Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital

    2 shared publications
  • Wei Zhong

    Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Diseases, National Health Commission (NHC) Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University

    2 shared publications
  • Xiaohong Lei

    Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Diseases, National Health Commission (NHC) Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University

    2 shared publications
  • Xiaoyun Li

    Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Diseases, National Health Commission (NHC) Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University

    2 shared publications

Latest Publications

  • Open Access

    Development and validation of a screening tool for sarcopenia in community-dwelling older adults: a diagnostic cross-sectional study

    by Huamei Yan, Yongli Chai, Yujie Zhang, Yunfan Zhan, Jiaqi Rong, Yanyan Song, Weian Yuan

    The early identification of sarcopenia, a condition linked to serious functional decline in older adults, is critical for intervention. However, there is c

  • Open Access

    Correction: Global assessment of hepatic safety in novel immunotherapies: a systematic review and meta-analysis

    by Minyan Ye, Yinuo Dong, Xiaoyun Li, Yang Zhi, Yuping Lu, Jieting Tang, Wei Zhong, Xiaohong Lei, Yimin Mao, Sha Huang, et al.

    • Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others. • Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated. Changing author order The order of authors in the author list of the published paper was erroneously given as: [Minyan Ye 1 , Yinuo Dong 2 , Xiaoyun Li 2,3 , Yang Zhi 2 , Yuping Lu 1 , Jieting Tang 2 , Wei Zhong 2 , Xiaohong Lei 2 , Yanyan Song 4 * , Sha Huang 1 * and Yimin Mao 2 * ] The correct author list reads: [Minyan Ye 1 , Yinuo Dong 2 , Xiaoyun Li 2,3 , Yang Zhi 2 , Yuping Lu 1 , Jieting Tang 2 , Wei Zhong 2 , Xiaohong Lei 2 , Yimin Mao 2 * , Sha Huang 1 * and Yanyan Song 4 * ] The original version of this article has been updated. The original version of this article has been updated.

  • Open Access

    Global assessment of hepatic safety in novel immunotherapies: a systematic review and meta-analysis

    by Minyan Ye, Yinuo Dong, Xiaoyun Li, Yang Zhi, Yuping Lu, Jieting Tang, Wei Zhong, Xiaohong Lei, Yimin Mao, Sha Huang, et al.

    Background: This study explored whether integrating innovative immunotherapies targeting costimulatory or co-inhibitory pathways beyond standard PD-1, PD-L1, and CTLA-4 treatments affects hepatic adverse events. We further analyzed liver-related side effects in patients with cancer receiving these novel therapies alone or in combination with others. Methods: Clinical studies on immunotherapies targeting molecules such as LAG-3, TIGIT, TIM-3, VISTA, CD47, ICOS, CD40, and B7-H3 were retrieved from PubMed, Embase, Cochrane Library, and Web of Science. Data from eligible studies that reported liver-related adverse events until May 2024 were included. Results: This analysis included 63 studies involving 7,327 patients. Among these, randomized controlled trials demonstrated that adding LAG-3 or TIGIT inhibitors to established therapies did not increase the risk of elevated hepatic enzyme levels or hepatitis. CD27-CD70-targeted monotherapy showed a strong association with elevated transaminase levels. Dual therapies combining 4-1BB agonists with PD-1/PD-L1 inhibitors resulted in >15% all-grade transaminase elevation, whereas CD40 agonists paired with immunotherapy resulted in >4% high-grade elevations. Immunotherapy-chemotherapy combinations showed high transaminase elevation rates. Overall, the incidence of elevated liver enzyme levels was similar between the single-agent and dual immunotherapy groups. The addition of chemotherapy or targeted therapy to single-agent immunotherapy increases the incidence of adverse events associated with elevated liver enzyme levels. The incidence of liver enzyme adverse events continued to increase with the addition of immunotherapy to the combination regimens. Cholestatic enzyme elevations were prominent in CD27-CD70 monotherapy and CD40 agonist combinations. Conclusions: This meta-analysis suggests adding LAG-3 or TIGIT inhibitors to existing therapies may not significantly increase hepatic toxicity. It reviewed adverse events from novel immunotherapies alone or combined with PD-1/PD-L1/CTLA-4 inhibitors, targeted agents, or chemotherapy. These findings have important clinical implications.

  • Open Access

    Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

    by Ying Qu, Yan-Yan Song, Cheng-Wei Chen, Qing-Chun Fu, Jun-Ping Shi, Yun Xu, Qing Xie, Yong-Feng Yang, Yong-Jian Zhou, Liang-Ping Li, et al.

    INTRODUCTION: To evaluate the diagnostic performance of ultrasound attenuation parameter (UAP) and liver stiffness measurement (LSM) by FibroTouch for diagnosis of hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). METHODS: We recruited 237 patients undergoing FibroTouch and liver biopsy within 2 weeks. The pathological findings of liver biopsy were scored by Nonalcoholic Steatohepatitis Clinical Research Network, and the diagnostic accuracy of UAP for steatosis and LSM for fibrosis was evaluated by area under the receiver operating characteristic curve (AUROC). The impacts of histological parameters on UAP and LSM were analyzed, and diagnostic performance of FibroTouch UAP and LSM was compared with other noninvasive biomarkers. RESULTS: The success rate of FibroTouch examination was 96.51%. The AUROC of UAP for diagnosis of steatosis ≥S1, ≥S2, and S3 was 0.88, 0.93, and 0.88, and the cutoff values were 244, 269, and 296 dB/m, respectively. The AUROC of LSM for the diagnosis of fibrosis stages ≥F2, ≥F3, and F4 was 0.71, 0.71, and 0.77, and the cutoff values were 9.4, 9.4, and 11 kPa, respectively. Multiple regression analysis showed that LSM was positively correlated with degree of fibrosis and NAFLD activity score. UAP was positively correlated with liver steatosis. The diagnostic performance of UAP for steatosis was significantly superior to that of the hepatic steatosis index. DISCUSSION: FibroTouch has a low failure rate with moderate to high diagnostic performance for discriminating the steatosis degree and fibrosis stage and is suitable for clinical evaluation and monitoring of patients with NAFLD.


  • Top Cited Papers
    Open Access

    Decision tree methods: applications for classification and prediction

    by Yan-Yan Song, Ying Lu

    Decision tree methodology is a commonly used data mining method for establishing classification systems based on multiple covariates or for developing prediction algorithms for a target variable. This method classifies a population into branch-like segments that construct an inverted tree with a root node, internal nodes, and leaf nodes. The algorithm is non-parametric and can efficiently deal with large, complicated datasets without imposing a complicated parametric structure. When the sample size is large enough, study data can be divided into training and validation datasets. Using the training dataset to build a decision tree model and a validation dataset to decide on the appropriate tree size needed to achieve the optimal final model. This paper introduces frequently used algorithms used to develop decision trees (including CART, C4.5, CHAID, and QUEST) and describes the SPSS and SAS programs that can be used to visualize tree structure.


  • Open Access

    The Use of Mixed Generalized Additive Modeling to Assess the Effect of Temperature on the Usage of Emergency Electrocardiography Examination among the Elderly in Shanghai

    by Wei-Ping Ma, Shuo Gu, Yi Wang, Xian-Jing Zhang, Ai-Rong Wang, Nai-Qing Zhao, Yan-Yan Song

    Acute coronary artery diseases have been observed to be associated with some meteorological variables. But few of the previous studies considered autocorrelated outcomes. Electrocardiography is a widely used tool in the initial diagnosis of acute cardiovascular events, and emergency electrocardiography counts were shown to be highly correlated with acute myocardial infarction in our pilot study, hence a good index of prediction for acute cardiovascular events morbidity among the elderly. To indirectly assess the impact of temperature on the number of acute cardiovascular events, we studied the association between temperature and emergency electrocardiography counts while considering autocorrelated nature of the response variables. We collected daily emergency electrocardiography counts for elderly females and males in Shanghai from 2007 to middle 2012, and studied temperature and other effects on these data using Mixed Generalized Additive Modelling methods. Delayed temperature effect distribution was described as the weighted average of the temperatures within 3 days before the counts was recorded. Autoregressive random effects were used in the model to describe the autocorrelation of the response variables. Temperature effect was observed to be piecewise linearly associated with the logarithm of emergency electrocardiography counts. The optimal weights of the delayed temperature effect distribution were obtained from the model estimation. The weights of lag-1 were the maximums, significantly greater than the weights of lag-2 and lag-3 for both females and males. The model showed good fit with R2 values of 0.860 for females and 0.856 for males. From the mixed generalized additive model, we infer that during cold and mild days, the number of emergency electrocardiography counts increase as temperature effect decreases, while during hot days, counts increase as temperature effect increases. Similar properties could be inferred for the occurrence of cardiovascular events.


  • Open Access

    Evaluation of the POSSUM, P-POSSUM and E-PASS scores in the surgical treatment of hilar cholangiocarcinoma

    by Hui Wang, Haolu Wang, Tao Chen, Xiaowen Liang, Yanyan Song, Jian Wang

    The Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM) model, its Portsmouth (P-POSSUM) modification and the Estimation of physiologic ability and surgical stress (E-PASS) are three surgical risk scoring systems used extensively to predict postoperative morbidity and mortality in general surgery. The aim was to undertake the first study of the predictive value of these models in patients undergoing surgical treatment of hilar cholangiocarcinoma. A retrospective analysis was performed on data collected prospectively over a 10-year interval from January 2003 to December 2012. The morbidity and mortality risks were calculated using the POSSUM, P-POSSUM and E-PASS equations. One hundred patients underwent surgical treatment of hilar cholangiocarcinoma. Complications were seen in 52 of 100 patients (52.0%). There were 10 postoperative in-hospital deaths (10.0%). Of 31 preoperative and intraoperative variables studied, operative type (P = 0.000), preoperative serum albumin (P = 0.003) and aspartate aminotransferase (P = 0.029) were found to be factors multivariate associated with postoperative complications. Intraoperative blood loss (P = 0.015), Bismuth-Corlette classification (P = 0.033) and preoperative hemoglobin (P = 0.041) were independent factors multivariate associated with in-hospital death. The POSSUM system predicted morbidity risk effectively with no significant lack of fit (P = 0.488) and an area under the ROC curve (AUC) of 0.843. POSSUM, P-POSSUM and E-PASS scores showed no significant lack of fit in calculating the mortality risk (P >0.05) and all yielded an AUC value exceeding 0.8. POSSUM had significantly more accuracy in predicting morbidity after major and major plus operations (O:E (observed/expected) ratio 0.98 and AUC 0.901) than after minor and moderate operations (O:E ratio 1.13 and AUC 0.759). POSSUM, P-POSSUM and E-PASS scores effectively predict morbidity and mortality in surgical treatment of hilar cholangiocarcinoma. However, improvements are still needed in the future because none of these scoring systems yielded an AUC value exceeding 0.9 for operations with all different levels of severity. Only POSSUM had more accuracy in predicting postoperative morbidity after operations with higher severity. This study was undertaken after obtaining approval from the ethics committee of School of Medicine, Shanghai Jiao Tong University with a trial registration number of http://www.stcsm.gov.cn/ .